Cardinal Health, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 162.47B | 181.33B | 204.98B | 226.83B | 222.58B | -1.9% | |
| Cost of Revenue | (155.69B) | (174.84B) | (198.10B) | (219.41B) | (214.41B) | -2.3% | |
Gross Profit | 6.78B | 6.48B | 6.89B | 7.41B | 8.17B | 10.2% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | (4.53B) | (4.51B) | (4.80B) | (5.00B) | (5.38B) | 7.6% | |
| Selling & Marketing | (4.53B) | — | — | (5.00B) | (5.38B) | 7.6% | |
| Depreciation & Amortization | (783.00M) | (692.00M) | (692.00M) | (710.00M) | (790.00M) | 11.3% | |
Operating Income (EBIT) | 472.00M | -607.00M | 752.00M | 1.24B | 2.27B | 83.0% | |
| Non-Operating Items | |||||||
| Interest Income | — | — | — | — | — | — | |
| Interest Expense | (180.00M) | (147.00M) | (84.00M) | (51.00M) | (215.00M) | 321.6% | |
| Other Income/Expenses (Net) | -149.00M | -177.00M | -89.00M | -42.00M | -174.00M | 314.3% | |
Income Before Tax | 323.00M | -784.00M | 663.00M | 1.20B | 2.10B | 74.9% | |
| Income Tax Expense | (289.00M) | (153.00M) | (332.00M) | (348.00M) | (532.00M) | 52.9% | |
Net Income | 611.00M | -938.00M | 330.00M | 852.00M | 1.56B | 83.2% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $2 | $-3 | $1 | $3 | $6 | 86.2% | |
| Weighted Avg Shares Outstanding | 292.00M | 279.00M | 261.00M | 245.00M | 241.00M | -1.6% | |
| Weighted Avg Shares Outstanding (Diluted) | 294.00M | 279.00M | 262.00M | 247.00M | 242.00M | -2.0% | |
EBITDA | 1.29B | 55.00M | 1.44B | 1.96B | 3.11B | 58.3% |
Explore CAH
CAH in the Healthcare
Large Cap